Ang Lifesciences India Profile
Key Indicators
- Authorised Capital ₹ 14.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 13.06 Cr
as on 24-10-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 81.62 Cr
as on 24-10-2024
- Satisfied Charges ₹ 13.33 Cr
as on 24-10-2024
- Revenue -37.98%
(FY 2023)
- Profit -101.67%
(FY 2023)
- Ebitda -82.99%
(FY 2023)
- Net Worth 2.46%
(FY 2023)
- Total Assets -6.02%
(FY 2023)
About Ang Lifesciences India
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 540694.
The Corporate was formerly known as Ang Lifesciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 14.00 Cr and a paid-up capital of Rs 13.06 Cr.
The company currently has active open charges totaling ₹81.62 Cr. The company has closed loans amounting to ₹13.33 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ang Lifesciences India Limited India are Saruchi Gupta as CFO and Renu Kaur as Company Secretary. Rajesh Gupta, Harvinder Dhami, Saruchi Gupta, and Three other members serve as directors at the Company.
- CIN/LLPIN
L24230PB2006PLC030341
- Company No.
030341
- Stock Symbol
BSE : 540694
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Amritsar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ang Lifesciences India Limited offer?
Ang Lifesciences India Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Anesthetic, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Anti Inflammatory Drugs, Methylprednisolone Injection, Thiopental Sodium Injections.
Who are the key members and board of directors at Ang Lifesciences India?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Gupta  | Managing Director | 14-Jun-2006 | Current |
| Saruchi Gupta | CFO | 21-Jun-2024 | Current |
| Renu Kaur | Company Secretary | 06-Aug-2021 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harvinder Dhami | Additional Director | 25-Jun-2024 | Current |
| Saruchi Gupta | Whole-Time Director and Cfo | 01-Apr-2011 | Current |
| Sukhpal Singh | Director | 02-May-2016 | Current |
| Chetna | Director | 12-Oct-2021 | Current |
| Rohit Mittal | Additional Director | 11-Oct-2023 | Current |
Financial Performance and Corporate Structure Insights of Ang Lifesciences India.
Ang Lifesciences India Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37.98% decrease. The company also saw a substantial fall in profitability, with a 101.67% decrease in profit. The company's net worth moved up by a moderate rise of 2.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ang Lifesciences India?
In 2023, Ang Lifesciences India had a promoter holding of 70.60% and a public holding of 29.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mansa Print And Publishers LimitedActive 21 years 4 monthsRajesh Gupta, Saruchi Gupta and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Mar 2024 | ₹5.00 Cr | Open |
Others Creation Date: 19 Oct 2022 | ₹5.00 Cr | Open |
Others Creation Date: 31 Mar 2022 | ₹1.80 M | Open |
How Many Employees Work at Ang Lifesciences India?
Ang Lifesciences India has a workforce of 459 employees as of Jul 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ang Lifesciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ang Lifesciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
